Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4470897
Max Phase: Preclinical
Molecular Formula: C22H22F2N4O3S
Molecular Weight: 460.51
Molecule Type: Unknown
Associated Items:
ID: ALA4470897
Max Phase: Preclinical
Molecular Formula: C22H22F2N4O3S
Molecular Weight: 460.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C#CCOc1cnc(/C(F)=C/c2ccc(F)c([C@]3(C)CS(=O)(=O)C(C)(C)C(N)=N3)c2)cn1
Standard InChI: InChI=1S/C22H22F2N4O3S/c1-5-8-31-19-12-26-18(11-27-19)17(24)10-14-6-7-16(23)15(9-14)22(4)13-32(29,30)21(2,3)20(25)28-22/h1,6-7,9-12H,8,13H2,2-4H3,(H2,25,28)/b17-10-/t22-/m0/s1
Standard InChI Key: MAJFETMMCMCMPJ-VBBNHBBTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 460.51 | Molecular Weight (Monoisotopic): 460.1381 | AlogP: 2.87 | #Rotatable Bonds: 5 |
Polar Surface Area: 107.53 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 6.71 | CX LogP: 1.96 | CX LogD: 1.88 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.69 | Np Likeness Score: -0.87 |
1. Hsiao CC, Rombouts F, Gijsen HJM.. (2019) New evolutions in the BACE1 inhibitor field from 2014 to 2018., 29 (6): [PMID:30709653] [10.1016/j.bmcl.2018.12.049] |
Source(1):